Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
FES-PET/CT in Invasive Lobular Carcinoma
NCT04252859Phase 2Terminated
- Sponsor
- University of Utah
- Start
- Dec 2020
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of fluoroestradiol f 18 in Invasive Lobular Carcinoma (ILC), sponsored by University of Utah. Started Dec 2020; status: terminated.
02
Drugs
fluoroestradiol f 18
03
Conditions
Invasive Lobular Carcinoma (ILC)
Beyond the preview
Go deeper on NCT04252859.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04252859.